Similarly, INHBA expression was significantly correlated with worse prognosis in breast cancer patients using probe set 210511_s_at [Figures 3E–G; OS HR (95%CI) = 1.35 (1.08–1.68), p = 0.0072; RFS HR (95%CI) = 1.23 (1.1–1.38), p = 0.00022; DMFS HR (95%CI) = 1.64 (1.33–2.02), P = 3e-06]. The gene discussed is INHBA; the disease is breast cancer.